Stakeholders' Involvement in Health Technology Assessment in Kazakhstan, Poland and Bulgaria

Lyazzat Kulembekova,David Hailey,Maksut Kulzhanov,Adlet Tabarov,Svetlin Georgiev,Magdalena Jaworzynska,Antoniya Yanakieva,Lyazzat Kosherbayeva

DOI: https://doi.org/10.2147/ppa.s455838

2024-05-23

Patient Preference and Adherence

Abstract:Lyazzat Kulembekova, 1 David Hailey, 2 Maksut Kulzhanov, 1 Adlet Tabarov, 3 Svetlin Georgiev, 4 Magdalena Jaworzynska, 5 Antoniya Yordanova Yanakieva, 4 Lyazzat Kosherbayeva 1, 6 1 Health Policy and Management Department, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan; 2 School of Information Sciences and Computer Technology, University of Wollongong, Wollongong, Australia; 3 Deputy Director of the National Center for Health Development, Ministry of Health, Astana, Kazakhstan; 4 Department HTA, Faculty of Public Health "prof. Tzecomir Vodenitcharov, MD, PhD, Dsc", Medical University, Sofia, Bulgaria; 5 Faculty of Economics, Maria Curie-Sklodowska University, Lublin, Poland; 6 Department of Health Policy and Organization, Al-Farabi Kazakh National University, Almaty, Kazakhstan Correspondence: Lyazzat Kosherbayeva, Asfendiyarov Kazakh National Medical University, 88 Tole Bi Street, Almaty, Kazakhstan, Email ; Background: In recent years, involvement of healthcare stakeholders in health technology assessment (HTA) has been discussed as helping the inclusion of social values in the decision-making process. The aim of our research was to identify and compare details from Kazakhstan, Poland and Bulgaria on their stakeholders' involvement in the HTA process. Information was sought on their identification, responsibilities, and regulation. Methods: We conducted a survey of seven types of stakeholders in the healthcare systems of Kazakhstan, Poland, and Bulgaria. They included patients and the public, providers, purchasers, payers, policy makers, product makers, and principal investigators. They were questioned on their involvement in the HTA process, and on the objectives of their participation. Results: Levels of involvement of different kinds of stakeholder varied between countries, reflecting political and administrative developments. There was full or partial agreement on the objectives of stakeholder participation. All respondents agreed that representatives of the ministry of health should be involved in selection of stakeholders for HTA. Conclusion: Progress has been made in the involvement of stakeholders, with interest in further development in all three countries. Keywords: health priorities, health policy, stakeholder involvement, Universal health coverage, health technology assessment In the development and reform of their health care systems, many countries have made use of health technology assessment (HTA). The purpose of HTA is to inform decision-making in order to promote an equitable, efficient, and high-quality health system. 1 HTA is a multidisciplinary process that uses explicit methods to determine the value of a health technology at different points in its lifecycle. 1 In the definition of HTA it was noted that the overall value may vary depending on the perspective taken (reflecting implications for the patient, relatives, caregivers, and the population), the stakeholders involved, and the decision context. 1 By involving stakeholders it is essential to take into account their objectives and expectations in the HTA process, informed judgments can be made about the value of specific health technologies, answering the questions of how and to what extent specific health technologies can help protect, restore, or enhance the health of specific patient groups. 2 The application of HTA in many countries is still evolving and there is some uncertainty on how the principles of HTA can be adopted by stakeholders in health care services. To ensure transparency in the HTA process, including social values and patient perspectives, 3 a number of countries actively involve stakeholders (formal and informal) in HTA. There are several barriers in involving different types of stakeholders and in the HTA process it is essential to take into account their needs and expectation. 4 HTA was first used in decision making in Kazakhstan in 2009, 5 in Poland 6 in 2005 and in Bulgaria in 2015. 7 The main purpose of HTA in the three countries to indicate it is used to inform decisions regarding the health technology being assessed and its availability within the health care system. HTA processes in Kazakhstan are regulated by the National Scientific Center for Health Development (NSCHD). Moreover, HTA reports are reviewed by the joint commission on the quality of medical services (JQC) of the Ministry of health (MoH), which includes representatives of the association, the experts from MoH and the NSCHD. In 2019–2020, the Project on "The Use of Evidence-Informed Deliberative P -Abstract Truncated-

medicine, general & internal